bluebird bio Inc banner

bluebird bio Inc
NASDAQ:BLUE

Watchlist Manager
bluebird bio Inc Logo
bluebird bio Inc
NASDAQ:BLUE
Watchlist
Price: 4.97 USD
Market Cap: $48.7m

Wall St Price Targets

BLUE Price Targets Summary
bluebird bio Inc

There are no price targets for BLUE.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
bluebird bio Inc Competitors:
Price Targets
FULT
Fulton Financial Corp
9% Upside
1981
Cathay Media and Education Group Inc
58% Upside
MRVL
Marvell Technology Group Ltd
-15% Downside

Revenue
Forecast

58% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
58% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 58%. The projected CAGR for the next 3 years is 46%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for bluebird bio Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for bluebird bio Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-73%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BLUE's stock price target?
Not Available

BLUE does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for bluebird bio Inc?
Projected CAGR
46%

Over the last 12 years, the compound annual growth rate for Revenue has been 58%. The projected CAGR for the next 3 years is 46%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett